This is a continuation study to evaluate efficacy in seizure patients who have participated in a previous protocol. It will study the long-term safety of Vigabatrin.
The aim of this study will be continued seizure control and the ability for continued use if drug is marketed.
Showing the most recent 10 out of 674 publications